Sign in
CompletedNo phase

Treatment for Diabetic Neuropathy Using Repetitive Transcranial Magnetic Stimulation

Key facts

Who runs it
McMaster University
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
18 people enrolled
Started
1 Jan 2025
Ended
31 Dec 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Sham Repetitive transcranial magnetic stimulation
  • Repetitive transcranial magnetic stimulation
Record updated
28 May 2026

Who can take part

Age
20 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • A diagnosis of diabetic neuropathy

Who cannot take part

  • Contraindications to transcranial magnetic stimulation
  • Known psychological diagnosis affecting comprehension
  • Inability to participate in the study

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this study is to determine whether a 4-week treatment of repetitive transcranial magnetic stimulation (rTMS) can alleviate the symptoms of neuropathy in individuals with diabetic neuropathy. The study will involve using questionnaires, nerve assessments, sensory tests, blood flow measurements, and blood tests to monitor any changes in symptoms after the rTMS intervention.

The 2 groups in the trial

  • Group A (Sham)Sham treatment, for comparison

    Participants in group A will take part in 4 weeks of treatment with 5 sessions per week. Each session will involve sham repetitive transcranial magnetic stimulation (rTMS). Sham rTMS will be delivered at 10 Hz, 2004 pulses targeting the leg representation of the primary motor cortex. Participants will hear and experience the clicking but will not be provided with any stimulation. Sham rTMS will take approximately 11.5 minutes.

    Treatment: Sham Repetitive transcranial magnetic stimulation

  • Group B (Active)Existing treatment, for comparison

    Participants in group B will take part in 4 weeks of treatment with 5 sessions per week. Each session will involve real repetitive transcranial magnetic stimulation (rTMS). rTMS will be delivered at 10 Hz, 2004 pulses targeting the leg representation of the primary motor cortex. rTMS will take approximately 11.5 minutes.

    Treatment: Repetitive transcranial magnetic stimulation

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effects of Repetitive Transcranial Magnetic Stimulation on Neuropathy in Diabetic Neuropathy: A Pilot Study
Record updated
28 May 2026